Population Pharmacokinetic-Pharmacodynamic Modelling of Angiotensin Receptor Blockade in Healthy Volunteers

By Csajka C.  

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 137-152

Adis International

Access to resources Recommend Favorite

Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 305-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-HT 1A receptor agonist, using a behavioural model in rats

By Vis P.   Della Pasqua O.   Kruk M.   Martin D.   Mocaer E.   Danhof M.   Jochemsen R.  

European Journal of Pharmacology, Vol. 414, Iss. 2, 2001-03 ,pp. : 233-243

Elsevier

Access to resources Recommend Favorite

Evaluation of the Potential Pharmacokinetic/Pharmacodynamic Interaction between Fluoxetine and Reboxetine in Healthy Volunteers

By Fleishaker J.C.  

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 141-150

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Studies of SK-896, a New Human Motilin Analogue, in Healthy Male Volunteers

By Furuta Y.  

Clinical Pharmacokinetics, Vol. 42, Iss. 6, 2003-01 ,pp. : 575-584

Adis International

Access to resources Recommend Favorite